AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Approved for NHS Use in England

Reported by Yahoo Finance · Published 22 Sep 2026, 9:38 AM MYT (1 d ago)

Image: Yahoo Finance

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Approved for NHS Use in England

Summary

More in Markets

The AI infrastructure trade is still not over, says this top-performing fund manager. Where he’s investing.

Dow Jones Futures: Nasdaq Hits New High; Sandisk, Micron Trigger Buy Signals

Bitcoin Is Down Just 1.2% for 2026 After Clearing $86,000. Can It End the Year Green?

Nobody Warned This Retired Teamster That a $5,100-a-Month Pension Makes 85% of His Social Security Taxable for Life

What Is Really Happening Beneath Boyd Group’s (BGSI) Record-Breaking Numbers?

Federal Reserve delivers warning to all Americans with a savings account: ‘There will be a reckoning.’ Are you ready?